Table 3. Associations between genotypes and the risk of developing ≥ 2 RP.
Multivariate analysis | Multivariate analysis | |||||||
---|---|---|---|---|---|---|---|---|
Genotypes | No. of patients | No. of events | HR | 95% CI | Pa value | HR | 95% CI | Pb value |
GSTP1:rs1695 | ||||||||
AA | 155 | 27 | 1 | 1 | ||||
GG+GA | 110 | 15 | 0.796 | 0.421–1.505 | 0.483 | 0.742 | 0.382–1.442 | 0.379 |
SOD2:rs4880 | ||||||||
AA | 200 | 33 | 1 | 1 | ||||
GG+AG | 65 | 9 | 0.888 | 0.424–1.862 | 0.753 | 1.068 | 0.503–2.268 | 0.864 |
GSTA1:rs3957356 | ||||||||
CC | 196 | 36 | 1 | 1 | ||||
TT+CT | 69 | 6 | 0.488 | 0.205–1.163 | 0.105 | 0.499 | 0.206–1.209 | 0.123 |
MTHFR:rs1801131 | ||||||||
TT | 171 | 36 | 1 | 1 | ||||
GG+GT | 94 | 6 | 0.272 | 0.120–0.656 | 0.004 | 0.339 | 0.137–0.839 | 0.019 |
MTHFR:rs1801133 | ||||||||
AA | 90 | 15 | 1 | 1 | ||||
GG+GA | 175 | 27 | 1.241 | 0.652–2.362 | 0.510 | 1.265 | 0.654–2.450 | 0.485 |
Pa values were calculated by Cox proportional model using multivariate analysis.
Pb values were calculated with adjustment for tumor location, stage, chemotherapy and V20.